Period of time： 2011年4期
Publisher： Future Medicine
Founded in： 2004
Total resources： 32
ISSN： 1475-0708
Subject： R Medicine and Health
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Therapy,volume 8,issue 4
Menu
Renal cell carcinoma: immunotherapy revisited
By Bukowski Ronald M in (2011)
Therapy,volume 8,issue 4 , Vol. 8, Iss. 4, 2011-07 , pp.
Access to resources
Recommend
Is partial nephrectomy a better surgical option for the treatment of renal cell carcinoma?
By Van Poppel Hein,Vandeursen Hendrik in (2011)
Therapy,volume 8,issue 4 , Vol. 8, Iss. 4, 2011-07 , pp.News & Views in ... Renal Cell Carcinoma
Therapy,volume 8,issue 4 , Vol. 8, Iss. 4, 2011-07 , pp.Cytokine therapy for renal cell cancer: the evolving role of immunomodulation
By Leary A,Larkin JM,Pickering Lisa M in (2011)
Therapy,volume 8,issue 4 , Vol. 8, Iss. 4, 2011-07 , pp.mTOR inhibitors in renal cell carcinoma
By Battelli Chiara,Cho Daniel C in (2011)
Therapy,volume 8,issue 4 , Vol. 8, Iss. 4, 2011-07 , pp.Therapeutic vaccines in renal cell carcinoma
By Schwaab Thomas,Ernstoff Marc S in (2011)
Therapy,volume 8,issue 4 , Vol. 8, Iss. 4, 2011-07 , pp.By MacFadyen Robert J in (2011)
Therapy,volume 8,issue 4 , Vol. 8, Iss. 4, 2011-07 , pp.Certolizumab pegol for the treatment of rheumatoid arthritis
By Modesto I,Spinello M,Nicchi F,Cottone M in (2011)
Therapy,volume 8,issue 4 , Vol. 8, Iss. 4, 2011-07 , pp.Update on vascular disrupting agents for cancer therapy
By Korpanty Grzegorz,Brekken Rolf A in (2011)
Therapy,volume 8,issue 4 , Vol. 8, Iss. 4, 2011-07 , pp.
Previous
Next